SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 62 filers reported holding SURFACE ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $327,624 | +21.0% | 376,750 | -2.8% | 0.00% | – |
| Q1 2023 | $270,870 | -21.2% | 387,625 | -7.6% | 0.00% | -100.0% |
| Q4 2022 | $343,930 | -23.2% | 419,425 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $448,000 | -25.8% | 430,365 | +16.8% | 0.00% | 0.0% |
| Q2 2022 | $604,000 | -37.3% | 368,424 | +12.3% | 0.00% | 0.0% |
| Q1 2022 | $964,000 | -30.3% | 328,004 | +13.3% | 0.00% | -50.0% |
| Q4 2021 | $1,384,000 | -26.1% | 289,619 | +17.1% | 0.00% | -33.3% |
| Q3 2021 | $1,872,000 | +56.8% | 247,227 | +54.5% | 0.00% | +50.0% |
| Q2 2021 | $1,194,000 | +50.0% | 159,997 | +56.8% | 0.00% | +100.0% |
| Q1 2021 | $796,000 | +113.4% | 102,023 | +152.8% | 0.00% | 0.0% |
| Q4 2020 | $373,000 | +139.1% | 40,350 | +78.9% | 0.00% | – |
| Q3 2020 | $156,000 | +52.9% | 22,550 | +45.5% | 0.00% | – |
| Q2 2020 | $102,000 | -83.7% | 15,500 | -59.6% | 0.00% | -100.0% |
| Q2 2018 | $627,000 | – | 38,391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $21,972,000 | 3.87% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,272,000 | 0.65% |
| Parkman Healthcare Partners LLC | 228,267 | $1,703,000 | 0.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 94,539 | $705,000 | 0.31% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $246,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 115,147 | $859,000 | 0.10% |
| Knights of Columbus Asset Advisors LLC | 113,594 | $847,000 | 0.08% |
| ARK Investment Management | 4,478,546 | $33,410,000 | 0.06% |
| Ipswich Investment Management Co., Inc. | 32,000 | $239,000 | 0.06% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 27,400 | $204,000 | 0.04% |